John Morrison
Corporate Officer/Principal chez PROTEOMICS INTERNATIONAL LABORATORIES LIMITED
Profil
John Chuck Morrison is currently the Director at GenePOC, Inc., XCR Diagnostics, Inc., and Head of Business Development at Proteomics International Laboratories Ltd.
He was formerly the Director at Avisa Pharma, Inc. Morrison received his undergraduate degree from the College of the Holy Cross (Massachusetts) and his undergraduate and MBA degrees from Boston University.
Postes actifs de John Morrison
Sociétés | Poste | Début |
---|---|---|
PROTEOMICS INTERNATIONAL LABORATORIES LIMITED | Corporate Officer/Principal | - |
GenePOC, Inc.
GenePOC, Inc. Medical SpecialtiesHealth Technology GenePOC, Inc. develops rapid molecular devices to detect genes at point-of-care. Its product includes an integrated portable instrument for the prevention and early detection of infectious diseases based on a centripetal technology platform. Its product also includes GenePOC disposable, a device for performing nucleic acid-based diagnostics at POC. The company’s products are also used for infectious disease, rapid food microbiology, and human pharmacogenetic testing applications. The company was founded by Michel G. Bergeron in 2007 and is headquartered in Quebec, Canada. | Director/Board Member | - |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Anciens postes connus de John Morrison
Sociétés | Poste | Fin |
---|---|---|
Avisa Pharma, Inc.
Avisa Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avisa Pharma, Inc. engages in the development of drug and device novel biomarker technology platform which enables the rapid detection of virulent bacterial pathogens within minutes. The company was founded by David Samuel Joseph in 2010 and is headquartered in Santa Fe, NM. | Director/Board Member | - |
Formation de John Morrison
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Boston University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PROTEOMICS INTERNATIONAL LABORATORIES LIMITED | Health Services |
Entreprise privées | 3 |
---|---|
Avisa Pharma, Inc.
Avisa Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avisa Pharma, Inc. engages in the development of drug and device novel biomarker technology platform which enables the rapid detection of virulent bacterial pathogens within minutes. The company was founded by David Samuel Joseph in 2010 and is headquartered in Santa Fe, NM. | Health Technology |
GenePOC, Inc.
GenePOC, Inc. Medical SpecialtiesHealth Technology GenePOC, Inc. develops rapid molecular devices to detect genes at point-of-care. Its product includes an integrated portable instrument for the prevention and early detection of infectious diseases based on a centripetal technology platform. Its product also includes GenePOC disposable, a device for performing nucleic acid-based diagnostics at POC. The company’s products are also used for infectious disease, rapid food microbiology, and human pharmacogenetic testing applications. The company was founded by Michel G. Bergeron in 2007 and is headquartered in Quebec, Canada. | Health Technology |
XCR Diagnostics, Inc.
XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Health Technology |